Waters Parkerson & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8M Sell
10,667
-6
-0.1% -$6.13K 0.63% 42
2026
Q1
$9.82M Sell
10,673
-57
-0.5% -$57.8K 0.5% 46
2025
Q4
$11.5M Sell
10,730
-121
-1% -$116K 0.57% 45
2025
Q3
$8.28M Sell
10,851
-46
-0.4% -$34.2K 0.4% 49
2025
Q2
$8.49M Sell
10,897
-91
-0.8% -$70.7K 0.42% 53
2025
Q1
$9.08M Buy
10,988
+241
+2% +$201K 0.48% 52
2024
Q4
$8.3M Buy
10,747
+208
+2% +$172K 0.44% 53
2024
Q3
$9.34M Buy
10,539
+34
+0.3% +$30.6K 0.47% 51
2024
Q2
$9.51M Sell
10,505
-306
-3% -$245K 0.51% 51
2024
Q1
$8.41M Buy
10,811
+463
+4% +$330K 0.43% 52
2023
Q4
$6.03M Buy
10,348
+453
+5% +$264K 0.33% 54
2023
Q3
$5.32M Sell
9,895
-153
-2% -$78.8K 0.32% 54
2023
Q2
$4.71M Sell
10,048
-25
-0.2% -$10.5K 0.27% 56
2023
Q1
$3.46M Hold
10,073
0.2% 57
2022
Q4
$3.69M Sell
10,073
-897
-8% -$318K 0.22% 56
2022
Q3
$3.55M Buy
10,970
+290
+3% +$91.9K 0.24% 57
2022
Q2
$3.46M Buy
10,680
+115
+1% +$34.5K 0.22% 56
2022
Q1
$3.02M Sell
10,565
-141
-1% -$36.3K 0.17% 59
2021
Q4
$2.96M Buy
10,706
+52
+0.5% +$13.2K 0.16% 59
2021
Q3
$2.46M Sell
10,654
-435
-4% -$107K 0.14% 65
2021
Q2
$2.54M Hold
11,089
0.15% 66
2021
Q1
$2.07M Hold
11,089
0.13% 70
2020
Q4
$1.87M Hold
11,089
0.13% 69
2020
Q3
$1.64M Hold
11,089
0.12% 68
2020
Q2
$1.82M Hold
11,089
0.15% 66
2020
Q1
$1.54M Buy
11,089
+120
+1% +$16.5K 0.15% 68
2019
Q4
$1.44M Sell
10,969
-400
-4% -$46.4K 0.11% 75
2019
Q3
$1.27M Hold
11,369
0.1% 77
2019
Q2
$1.26M Sell
11,369
-1,000
-8% -$118K 0.1% 77
2019
Q1
$1.6M Sell
12,369
-3,316
-21% -$403K 0.13% 70
2018
Q4
$1.81M Sell
15,685
-600
-4% -$67K 0.18% 65
2018
Q3
$1.75M Buy
16,285
+130
+0.8% +$13K 0.14% 68
2018
Q2
$1.38M Sell
16,155
-668
-4% -$54.9K 0.12% 71
2018
Q1
$1.3M Sell
16,823
-25
-0.1% -$2.01K 0.11% 70
2017
Q4
$1.42M Sell
16,848
-250
-1% -$21.3K 0.12% 69
2017
Q3
$1.46M Buy
17,098
+3,125
+22% +$256K 0.13% 72
2017
Q2
$1.15M Hold
13,973
0.11% 78
2017
Q1
$1.18M Sell
13,973
-500
-3% -$40K 0.11% 78
2016
Q4
$1.06M Sell
14,473
-350
-2% -$26.1K 0.11% 78
2016
Q3
$1.19M Buy
14,823
+400
+3% +$32K 0.12% 74
2016
Q2
$1.14M Sell
14,423
-400
-3% -$30.1K 0.12% 75
2016
Q1
$1.07M Hold
14,823
0.12% 76
2015
Q4
$1.25M Hold
14,823
0.14% 73
2015
Q3
$1.24M Sell
14,823
-450
-3% -$38K 0.16% 72
2015
Q2
$1.27M Sell
15,273
-255
-2% -$19.4K 0.15% 74
2015
Q1
$1.13M Buy
15,528
+200
+1% +$14.2K 0.13% 76
2014
Q4
$1.06M Hold
15,328
0.13% 78
2014
Q3
$994K Sell
15,328
-1,650
-10% -$104K 0.12% 78
2014
Q2
$1.06M Hold
16,978
0.13% 78
2014
Q1
$999K Sell
16,978
-1,500
-8% -$83.7K 0.12% 79
2013
Q4
$942K Sell
18,478
-200
-1% -$10K 0.12% 80
2013
Q3
$940K Sell
18,678
-1,800
-9% -$94.2K 0.13% 77
2013
Q2
$1.01M Buy
+20,478
New +$1.11M 0.15% 71

Other funds holding LLY

Waters Parkerson & Co's LLY Position: Q2 2026 in Review

Waters Parkerson & Co reduced its Eli Lilly (LLY) stake by 0.06% in Q2 2026, selling an estimated $6.13K and leaving 10,667 shares worth $12.8M. The position accounts for 0.63% of the portfolio, ranked #42.

Waters Parkerson & Co first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 3,051 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Waters Parkerson & Co held 10,667 shares of Eli Lilly worth $12.8M as of Q2 2026.
  • Waters Parkerson & Co sold 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
  • Eli Lilly made up 0.63% of Waters Parkerson & Co's portfolio in Q2 2026, its #42 holding.
  • Waters Parkerson & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 3,051 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Waters Parkerson & Co's 13F filing for Q2 2026, filed 30 Jul 2026.